Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Indolent B-Cell Non-Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00060684
What this trial is testing

Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Low-GradeLymphoma, Small LymphocyticLymphoma, Mixed-Cell, Follicular+1 more
CTI BioPharma 30
Not applicableEnded earlyNCT02928510
What this trial is testing

Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma

Who this might be right for
Absence of Signs or SymptomsB-Cell Non-Hodgkin LymphomaDigestive System Signs and Symptoms+5 more
Jonsson Comprehensive Cancer Center 1
Early research (Phase 1)Study completedNCT01429025
What this trial is testing

Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Refractory or Relapsed Indolent Non-Hodgkin Lymphoma

Who this might be right for
Refractory/Relapsed Indolent Non-Hodgkin Lymphoma
Alliance for Clinical Trials in Oncology 26
Early research (Phase 1)WithdrawnNCT05934097
What this trial is testing

FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaTransformed Indolent Non-Hodgkin's LymphomaFollicular Lymphoma+2 more
Fate Therapeutics
Testing effectiveness (Phase 2)Study completedNCT00220285
What this trial is testing

Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaLymphoma, B-CellLymphoma, Low-Grade
Bayer 45
Not applicableNot Yet RecruitingNCT07609446
What this trial is testing

Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma

Who this might be right for
Indolent LymphomaFollicular LymphomaMarginal Zone Lymphoma+1 more
The First Affiliated Hospital of Soochow University 30
Not applicableLooking for participantsNCT05876923
What this trial is testing

The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients

Who this might be right for
Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaIndolent Non-hodgkin Lymphoma
Mayo Clinic 70
Testing effectiveness (Phase 2)Study completedNCT01239394
What this trial is testing

Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma

Who this might be right for
Follicular LymphomaMarginal Zone LymphomaSmall Lymphocytic Lymphoma
Massachusetts General Hospital 43
Testing effectiveness (Phase 2)Looking for participantsNCT05672251
What this trial is testing

Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Grade 3b Follicular LymphomaRecurrent High Grade B-Cell Lymphoma+9 more
City of Hope Medical Center 36
Testing effectiveness (Phase 2)WithdrawnNCT01238146
What this trial is testing

Obatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+4 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06458439
What this trial is testing

Epcoritamab-CAR T Cells for Large B-cell Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinRelapsed Diffuse Large B Cell LymphomaRefractory Diffuse Large B-cell Lymphoma+2 more
Abramson Cancer Center at Penn Medicine 31
Testing effectiveness (Phase 2)Study completedNCT00612183
What this trial is testing

Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaMantle Cell Lymphoma
SymBio Pharmaceuticals 56
Testing effectiveness (Phase 2)WithdrawnNCT00003605
What this trial is testing

Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Hoag Memorial Hospital Presbyterian
Large-scale testing (Phase 3)UnknownNCT02867553
What this trial is testing

Multiple Fields Radiotherapy Versus Intravenous Rituximab in the Treatment of Indolent Cutaneous Lymphomas B-cell With Multiple or Recurrent Lesions

Who this might be right for
Indolent Cutaneous B Cell Lymphomas
CHU de Reims 36
Large-scale testing (Phase 3)Ended earlyNCT01289223
What this trial is testing

A Trial to Investigate the Efficacy of Bendamustine in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Refractory to Rituximab.

Who this might be right for
Indolent B-cell NHL
Mundipharma Research Limited 88
Large-scale testing (Phase 3)UnknownNCT00091676
What this trial is testing

Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
Biovest International 629
Early research (Phase 1)Study completedNCT00052416
What this trial is testing

Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Beth Israel Deaconess Medical Center
Early research (Phase 1)Study completedNCT00082784
What this trial is testing

Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms

Who this might be right for
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+10 more
National Cancer Institute (NCI) 93
Testing effectiveness (Phase 2)Study completedNCT00723099
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+23 more
Fred Hutchinson Cancer Center 73
Early research (Phase 1)Active Not RecruitingNCT05753501
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Who this might be right for
Hematologic Cancer
AbbVie 135
Next Page